PerkinElmer may invest over USD100 mn in India by 2022

 14-Dec-17, ET Healthworld 

American health technology firm PerkinElmer may invest over USD100 mn in tie-ups with the government and acquisitions mainly in reproductive health by 2022. The company, which acquired one of India's largest providers of in-vitro diagnostic products earlier in 2017, is in talks with various government bodies and start-ups for potential investments.

Image: ET Healthworld

The firm is reaching out to the Ministry of Health and Family Welfare to invest in national programs like the Rashtriya Bal Swasthya Karyakram - an initiative aimed at early identification and intervention for children from birth to 18 years. 

It is also in "exploratory" talks for acquisitions of start-ups in areas like pre-natal and neo-natal health technologies, according to Prahlad Singh, PerkinElmer's diagnostics president.

 Read the full article  

 Healthcare insights